Xueyan Chen

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Radical Prostatectomy

Prostate Cancer

Ejection Fraction

Ulcerative Colitis

Top Venues

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)